Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
2,396
Views
4
CrossRef citations to date
0
Altmetric
Neurology
Modelling the value of innovative treatments for Alzheimer’s disease in the United States
Charles Makina Medical Health Outcomes Research, Biogen, Cambridge, MA, USACorrespondence[email protected]
, Peter Neumannb Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
, Sue Peschinc Alliance for Aging Research, Washington, DC, USA
& Dana Goldmand Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA
Pages 764-769
|
Received 04 Mar 2021, Accepted 05 May 2021, Published online: 04 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.